CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report) shares saw unusually-high trading volume on Tuesday . Approximately 74,552 shares traded hands during trading, an increase of 233% from the previous session’s volume of 22,376 shares.The stock last traded at $68.2310 and had previously closed at $68.95.
Analysts Set New Price Targets
Separately, Royal Bank Of Canada upgraded shares of CochLear from a “hold” rating to a “moderate buy” rating in a research note on Monday, January 19th. Two investment analysts have rated the stock with a Strong Buy rating, one has given a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, CochLear currently has an average rating of “Buy”.
Read Our Latest Analysis on CochLear
CochLear Stock Performance
About CochLear
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Read More
- Five stocks we like better than CochLear
- VWAV: Riding the Defense Surge
- Silver $500? The “Deficit Math” says it’s possible.
- Unlocked: Elon Musk’s Next Big IPO
- This makes me furious
- The Foundation Behind Today’s Biggest Tech Trends
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
